Terms: = Lymphoma AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Prognosis
37 results:
1. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
[TBL] [Abstract] [Full Text] [Related]
2. Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.
Zhang C; Mou B; Xu J; Wang J; Liu Q; Yang Y; Tang W; Zhong X; Xu C
Br J Haematol; 2023 Dec; 203(5):807-819. PubMed ID: 37646306
[TBL] [Abstract] [Full Text] [Related]
3. Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review.
Jin X; Liu H; Li J; Xiao X; Yuan X; Chen P; Chen B; Liang Y; Huang F
J Zhejiang Univ Sci B; 2023 Aug; 24(8):711-722. PubMed ID: 37551557
[TBL] [Abstract] [Full Text] [Related]
4. [Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma].
Shi YF; Wang HJ; Liu WP; Mi L; Long MP; Liu YF; Lai YM; Zhou LX; Diao XT; Li XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):521-529. PubMed ID: 37291929
[TBL] [Abstract] [Full Text] [Related]
5. A nodal EBV-positive T cell lymphoma with a T follicular helper cell phenotype.
Zhang Z; Wang W; Li Y; Xu Z; Wu H; Wang Z
Histopathology; 2023 Jul; 83(1):137-142. PubMed ID: 37071061
[TBL] [Abstract] [Full Text] [Related]
6. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma.
Kameda T; Kataoka K; Kamiunten A; Hidaka M; Miyoshi H; Nakano N; Nosaka K; Yoshimitsu M; Yasunaga JI; Kogure Y; Shide K; Miyahara M; Sakamoto T; Akizuki K; Hidaka T; Kubuki Y; Koya J; Kawano N; Yamashita K; Kawano H; Toyama T; Maeda K; Marutsuka K; Imaizumi Y; Kato K; Sugio T; Tokunaga M; Tashiro Y; Takaori-Kondo A; Miyazaki Y; Akashi K; Ishitsuka K; Matsuoka M; Ohshima K; Watanabe T; Kitanaka A; Utsunomiya A; Ogawa S; Shimoda K
Haematologica; 2023 Aug; 108(8):2178-2191. PubMed ID: 36794502
[TBL] [Abstract] [Full Text] [Related]
7. Tumor mutation burden involving epigenetic regulatory genes and the rhoa GTPase predicts overall survival in nodal mature T-cell lymphomas.
de Pádua Covas Lage LA; Culler HF; Barreto GC; Reichert CO; Levy D; de Oliveira Costa R; Rocha V; Pereira J
Clin Epigenetics; 2022 Dec; 14(1):180. PubMed ID: 36536430
[TBL] [Abstract] [Full Text] [Related]
8. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J
Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687
[TBL] [Abstract] [Full Text] [Related]
9. [The Effect of Bcl-6 Expression on the prognosis of Newly Treated Double-Expressing lymphoma Treated with R-CHOP Regimen].
Fan BJ; Chen H; Shangguan CX; Liu XY; Chang Y; Zhang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1797-1801. PubMed ID: 34893113
[TBL] [Abstract] [Full Text] [Related]
10. Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers.
Mihashi Y; Kimura S; Iwasaki H; Oshiro Y; Takamatsu Y; Kawauchi S; Shimajiri S; Ishizuka K; Takeshita M
Diagn Pathol; 2021 Nov; 16(1):101. PubMed ID: 34742294
[TBL] [Abstract] [Full Text] [Related]
11. Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents.
Au-Yeung RKH; Richter J; Iaccarino I; Abramov D; Bacon CM; Balagué O; d'Amore ESG; Simonitsch-Klupp I; Hebeda K; Nakazawa A; Oschlies I; Kontny U; Woessmann W; Burkhardt B; Klapper W
Pediatr Blood Cancer; 2021 Nov; 68(11):e29285. PubMed ID: 34390161
[TBL] [Abstract] [Full Text] [Related]
12. Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.
Lemonnier F; Safar V; Beldi-Ferchiou A; Cottereau AS; Bachy E; Cartron G; Fataccioli V; Pelletier L; Robe C; Letourneau A; Missiaglia E; Fourati S; Moles-Moreau MP; Delmer A; Bouabdallah R; Voillat L; Becker S; Bossard C; Parrens M; Casasnovas O; Cacheux V; Régny C; Camus V; Delfau-Larue MH; Meignan M; de Leval L; Gaulard P; Haioun C
Blood Adv; 2021 Jan; 5(2):539-548. PubMed ID: 33496747
[TBL] [Abstract] [Full Text] [Related]
13. Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains.
Sakihama S; Morichika K; Saito R; Miyara M; Miyagi T; Hayashi M; Uchihara J; Tomoyose T; Ohshiro K; Nakayama S; Nakachi S; Morishima S; Sakai K; Nishio K; Masuzaki H; Fukushima T; Karube K
Cancer Sci; 2021 Mar; 112(3):1300-1309. PubMed ID: 33426772
[TBL] [Abstract] [Full Text] [Related]
14. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
Zhang P; Zhang M
Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
[TBL] [Abstract] [Full Text] [Related]
15. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017.
Holm F; Mikkelsen LH; Kamper P; Rasmussen PK; Larsen TS; Sjö LD; Heegaard S
Br J Ophthalmol; 2021 Jul; 105(7):914-920. PubMed ID: 32732342
[TBL] [Abstract] [Full Text] [Related]
16. Angioimmunoblastic T-cell lymphoma in Taiwan reveals worse progression-free survival for
Hsu YT; Wang YC; Chen RY; Hung LY; Li SS; Yen CC; Chen TY; Medeiros LJ; Chang KC
Leuk Lymphoma; 2020 May; 61(5):1108-1118. PubMed ID: 31870198
[TBL] [Abstract] [Full Text] [Related]
17. [Angioimmunoblastic T-cell lymphoma: histopathological grading and prognosis].
Guo YM; Liu XF; Jiao LJ; Yin SY; Wang Z; Li XX; Ma ZP; Yang JM; He MX
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):784-790. PubMed ID: 31594043
[No Abstract] [Full Text] [Related]
18. [Current standard in diagnostic and therapy of peripheral T-cell lymphoma].
Hopfinger G; Staber P
Dtsch Med Wochenschr; 2019 Oct; 144(20):1400-1404. PubMed ID: 31594013
[TBL] [Abstract] [Full Text] [Related]
19. Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell lymphoma.
Liu X; Wu T; Zhu SY; Shi M; Su H; Wang Y; He X; Xu LM; Yuan ZY; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Qi SN; Yang Y; Li YX
JAMA Netw Open; 2019 Mar; 2(3):e190194. PubMed ID: 30821826
[TBL] [Abstract] [Full Text] [Related]
20. Wnt5a and ROR1 activate non-canonical Wnt signaling via rhoa in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
[TBL] [Abstract] [Full Text] [Related]
[Next]